Exclusive Interviews

Yehuda Handelsman, MD, FACP, FNLA, MACE is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. He is a nationally and internationally recognized authority on Diabetes, Lipids, Obesity, HTN and the prevention of cardiovascular disease.

In this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about his presentation on the contemporary approach to the management of diabetes as a cardiovascular disease.

In this exclusive interview transcript, Dr. Handelsman discusses the relationship between diabetes and cardiovascular disease, and the impact new diabetes drugs are having on management of both conditions.

In part 1 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about his work as an endocrinologist, and about why diabetes is a cardiovascular disease.

In part 2 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about changing diabetes guidelines and what we've learned through studies of new diabetes drugs.

In part 3 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about why the ACP changed A1C guidelines to 7% in their 2018 recommendations, and why he believes the new guideline is influenced by outdated research.

In part 4 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about Heart in Diabetes program and the World Congress on Insulin Resistance.

In part 5, the conclusion of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about possible future breakthroughs in diabetes devices and therapies.

In part 5, the conclusion of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about upcoming research studies on patient adherence.

In part 4 of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about his interest in the comparative analysis of various drug classes and their real-world implications.